Lynn Malec – The New Director of the CCBD and Pharmacy at Children’s Wisconsin
Versiti Inc shared on LinkedIn:
”Versiti is proud to announce the promotion of Lynn Malec, MD, MSc, to Program Director of the Comprehensive Center for Bleeding Disorders (CCBD) and Pharmacy at Children’s Wisconsin.
Since joining Versiti in 2016, Dr. Malec has led transformative advances in bleeding disorder care, including launching our gene therapy program for hemophilia B, which made Versiti one of the first centers in the U.S. to administer the FDA-approved therapy HEMGENIX.
Her internationally recognized research and compassionate leadership continue to expand access to breakthrough treatments and whole-person care for patients and families.
Learn more about our commitment to advancing hope through science.”
More winner stories featured in Hemostasis Today.
-
Feb 15, 2026, 07:24Ekaterina Balaian Extends Sincere Gratitude to The Team at The Yeolyan Hematology and Oncology Center
-
Feb 15, 2026, 07:10Brijesh Kumar: Stroke Rehabilitation Needs Scalable and Evidence-Based Models
-
Feb 15, 2026, 06:58Reza Hosseini Ghomi: A New Tool Predicts The Onset of Dementia After Stroke
-
Feb 15, 2026, 06:45Mohamed Rawy: Clinical Pearls of Clopidogrel
-
Feb 15, 2026, 06:24Pall T. Onundarson: Would Modern Monitoring Alter VKAs Role in High-Risk COPD with AF Patients
-
Feb 15, 2026, 06:12Jeyaraj Pandian: Stroke Mortality in Rural Ludhiana
-
Feb 15, 2026, 06:04GENB-OAC Study Insights from Gabrielle Sarlon and The Team
-
Feb 15, 2026, 05:46Victor Schulze-Zachau: Comparing Perforation and Outcomes in MVO and LVO Thrombectomy
-
Feb 15, 2026, 04:58Rian Hollister: PlasmaFlow As An Option for Continued DVT Prevention